期刊文献+

黄酮类化合物对肿瘤多药耐药调节作用的研究进展 被引量:10

Current studies on modulation of cancer multidrug resistance by flavonoids
原文传递
导出
摘要 多药耐药是临床上化疗失败的重要原因之一。黄酮类化合物存在于多种植物中,具有广泛的药理活性,对P-糖蛋白(P-gp)、多药耐药相关蛋白(MRP)、乳腺癌耐药蛋白(BCRP)等外向转运蛋白的抑制作用使其可能成为肿瘤多药耐药调节剂。文中分别对黄酮类化合物对ABC家族转运蛋白抑制作用的研究概况、作用机制以及构效关系进行综述,为肿瘤多药耐药抑制剂的开发和应用提供重要信息。 Multi-drug resistance(MDR) is one of the key causes of failures in cancer chemotherapy. Flavonoids are broadly distributed in plants and have multiple pharmacological activities. The flavonoids may be possible modulators of MDR because they have inhibitory activity on drug transporters, such as P-gp, MRP and BCRP. This article summarized the inhibitory effects of flavonoids on ABC transporters in aspects of research process, action mechanism and structure-activity relationship, in order to provide important information for development and application of the modulators.
出处 《中国新药杂志》 CAS CSCD 北大核心 2010年第2期109-113,共5页 Chinese Journal of New Drugs
关键词 黄酮类化合物 ABC转运蛋白 P-糖蛋白 多药耐药相关蛋白 乳腺癌耐药蛋白 多药耐药 flavonoids ABC transporter P-glycoprotein (P-gp) multidrug resistance associated protein (MRP) breast cancer resistance protein(BCRP) multidrug resistance(MDR)
  • 相关文献

参考文献28

  • 1TSURUO T. Molecular cancer therapeutics:recent progress and targets in drug resistance [ J ]. Intern Med,2003,42 (3) :237 - 243.
  • 2GILLET JP, EFFERTH T, REMACLE J. Chemotherapy-induced resistance by ATP-binding cassette transporter genes [ J ]. Biochim Biophys Acta,2007,1775 ( 2 ) :237 - 262.
  • 3ZHANG SZ, MORRIS ME. Effects of the flavonoids biochanin A, morin,phloretin,and silymarin on P-glycoprotein-mediated transport[ J]. J Pharmacol Exp Ther,2003,304 (3) : 1258 - 1267.
  • 4MCDEVITT CA, CALLAGHAN R. How can we best use structural information on P-glyeoprotein to design inhibitors[ J]. Pharmacol Ther,2007,113 ( 2 ) : 429 - 441.
  • 5RAUCH C,PLUEN A. Multi drug resistance-dependent ' vacuum cleaner' functionality potentially driven by the interactions between endocytnsis, drug size and Pgp-like transporters surface density [ J ]. Eur Biophys J, 2007,36 ( 2 ) : 121 - 131.
  • 6BOUMENDJEL A,PIETRO AD,DUMONTET C,et al. Receat advances in the discovery of flavonoids and analogs with high-affinity binding to P-glycoprotein responsible for cancer cell multidrng resistance [ J ]. Med Res Rev,2002,22 ( 5 ) :512 - 529.
  • 7CHAN KF,ZHAO YZ,BURKETT BA,et al. Flavonoid dimers as bivalent modulators for P-glycoprotein-based muhidrug resistance: synthetic apigenin homodimers linked with defined-length pory( ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells[ J]. J Med Chem,.
  • 8QIAN F, WEI DZ,ZHANG Q,et al. Modulation of P-glycoprotein function and reversal of muhidrug resistance by( - )-epigallocatechin gallate in human cancer cell [ J ]. Biomed Pharmacother, 2005,59 ( 3 ) :64 - 69.
  • 9KITAGAWA S. Inhibitory effects of polyphenols on P-glycoproteinmediated transport [ J ]. Biol Pharm Bull ,2006,29 ( 1 ) : 1 - 6.
  • 10LIU XL,TEE HW,GO ML. Functionalized chalcones as selective inhibitors of P-glycoprotein and breast cancer resistance protein [ J ]. Bioorg Med Chem,2008,16 ( 1 ) : 171 - 180.

同被引文献80

引证文献10

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部